IQVIA HOLDINGS INC.
Ownership & governance
Executives 5Directors 9Avg age 63Avg tenure 6y
AB
Ari Bousbib
Chief Executive Officer
Age 64Since 2016-10-02Profile →
+13
Executives5
AB
Ari Bousbib→
Chief Executive Officer
Age 64Since 2016-10-02
MF
Michael Fedock
Director of Finance/CFO
Age 51Since 2026-02-27
RK
Rob Kotchie
Chief Tech/Sci/R&D Officer
—Since 2025-12-31
BH
Bernd Haas
Chief Tech/Sci/R&D Officer
Age 50Since 2025-11-30
JS
Jeffrey Spaeder
Chief Tech/Sci/R&D Officer
——
Board of directors9
JL
John Leonard→
Director/Board Member
Age 68Since 2015-02-04
AB
Ari Bousbib→
Chairman
Age 64Since 2016-10-02
JD
John Danhakl→
Director/Board Member
Age 69Since 2016-10-02
JF
Jim Fasano→
Director/Board Member
Age 56Since 2016-10-02
CG
Colleen Goggins→
Director/Board Member
Age 70Since 2017-07-26
CB
Carol Burt→
Director/Board Member
Age 68Since 2019-02-20
LM
Leslie Morris→
Director/Board Member
Age 55Since 2022-01-23
SS
Sheila Stamps→
Director/Board Member
Age 68Since 2022-01-25
Shareholders4
| Name | Stake | Shares |
|---|---|---|
| Harris Associates LP | 7.3 % | 12,183,275 |
| Vanguard Capital Management LLC | 6.607 % | 11,026,983 |
| BlackRock Advisors LLC | 6.317 % | 10,543,555 |
| Vanguard Portfolio Management LLC | 4.539 % | 7,576,001 |
Catalog · 2026-07-09
Proxy officers17
| Name | Role | Since | Shares |
|---|---|---|---|
| Ari Bousbib | Chairman | 2016-10-02 | - |
| Alistair R. Grenfell | Director or executive officer | — | 63,490 |
| Carol Burt | Director/Board Member | 2019-02-20 | - |
| Carol J. Burt | Director or executive officer | 2019-01-01 | 8,601 |
| Colleen A. Goggins | Director or executive officer | 2017-01-01 | 17,584 |
| Colleen Goggins | Director/Board Member | 2017-07-26 | - |
| Eric M. Sherbet | Director or executive officer | — | 93,170 |
| James A. Fasano | Director or executive officer | 2016-01-01 | 5,126 |
Proxy · as of 2026-07-09
Group companies
| Name | Category |
|---|---|
| IQVIA RDS (India) Pvt Ltd. | Miscellaneous Commercial Services |
| 159 Technology Solutions Pvt Ltd. | — |
| IQVIA Analytics Services Pvt Ltd. | Miscellaneous Commercial Services |
| Excel Life Sciences Pvt Ltd. | — |
| Excel Life Sciences Pvt Ltd. | — |
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 297Range 250–345Analysts 19
250Mean 297345
- Strong buy 3
- Buy 16
- Hold 3
Broker actions40 of 257
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Stifel | Maintained | Buy | 303 | 2026-10-14 |
| Mizuho | Maintained | Outperform | 300 | 2026-10-07 |
| Barclays | Maintained | Overweight | 300 | 2026-10-07 |
| RBC Capital | Maintained | Outperform | 319 | 2026-09-29 |
| Truist Securities | Reiterated | Buy | 329 | 2026-09-28 |
| Morgan Stanley | Maintained | Equal-Weight | 270 | 2026-09-17 |
| JP Morgan | Maintained | Overweight | 285 | 2026-07-29 |
| Stifel | Maintained | Buy | 276 | 2026-07-29 |
| TD Cowen | Maintained | Buy | 288 | 2026-07-29 |
| RBC Capital | Maintained | Outperform | 247 | 2026-07-29 |
| BMO Capital | Maintained | Outperform | 270 | 2026-07-29 |
| Baird | Maintained | Outperform | 287 | 2026-07-29 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.